This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Merrf Syndrome
Information about Merrf Syndrome: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Merrf Syndrome
Most recent studies have shown that Merrf Syndrome shares some biological mechanisms with acidosis, acidosis-lactic, ataxia, atrophy, chronic-progressive-external-ophthalmoplegia, encephalopathies, epilepsies-myoclonic, epilepsy, external-ophthalmoplegia, kearns-sayre-syndrome, leigh-disease, melas-syndrome, mitochondrial-diseases, mitochondrial-encephalomyopathies, mitochondrial-myopathies, myoclonus, myopathy, ophthalmoplegia.
Among the many pathways, these few ones have gauged particular interests from scientists studying Merrf Syndrome, and have been seen in publications frequently: Aging, Cardiac Conduction, Cell Death, Cell Growth, Dna Replication, Electron Transport, Electron Transport Chain, Excretion, Hormone Secretion, Lipid Storage, Localization, Mitochondrial Dna Replication, Mitochondrial Translation, Oxidative Phosphorylation, Pathogenesis, Reflex, Secretion, Senescence, Translation, Transport
Quite a number of genes have been found to play important roles in Merrf Syndrome, such as CDKN1A, COX5A, COX8A, CPOX, CSTB, CYCS, HSPB1, INS, MRRF, NPTX2, POLG, RHO, RHOD, SDS, TK2, TRMU, TYMP. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.